Astria Therapeutics Inc. (ATXS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Astria Therapeutics Inc.

    NASDAQ: ATXS · Real-Time Price · USD
    7.52
    -0.17 (-2.21%)
    At close: Oct 03, 2025, 3:59 PM
    7.80
    3.72%
    After-hours: Oct 03, 2025, 06:33 PM EDT

    Astria Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 59.82M 175.53M 20.52M 86.51M
    Short-Term Investments
    		 268.31M 71M 205.91M 39M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 2.61M 3.36M 2M 45K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 6.51M 163K n/a 121K
    Total Current Assets
    		 334.64M 250.94M 227.69M 127.08M
    Property-Plant & Equipment
    		 5.11M 363K 948K 394K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 7.72M 3.72M 2.94M 439K
    Total Assets
    		 342.36M 254.67M 230.63M 127.51M
    Account Payables
    		 4.32M 1.51M 788K 1.56M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 1.38M 329K 582K 365K
    Other Current Liabilities
    		 -1.38M 3.72M 3.73M 1.59M
    Total Current Liabilities
    		 19.13M 11.55M 9.06M 5.2M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 3.97M n/a 357K 1.92M
    Total Liabilities
    		 23.1M 11.55M 9.42M 5.2M
    Total Debt
    		 5.35M 329K 939K 365K
    Book Value
    		 319.26M 243.12M 221.22M 122.31M
    Book Value Per Share
    		 5.68 8.07 15.13 13.70
    Common Stock
    		 57K 41K 28K 13K
    Retained Earnings
    		 -674.79M -580.53M -507.64M -455.81M
    Comprehensive Income
    		 163K n/a -79K n/a
    Shareholders Equity
    		 319.26M 243.12M 221.22M 122.31M
    Total Investments
    		 268.31M 71M 205.91M 39M

    Add to Watchlist